SCHEMBL3972617

SCHEMBL3972617

CCCCc1ccc(-c2c(S)nnn2-c2cccc(O)c2O)c(C)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
NFKB1 P19838 2/20 0.38
NFKB2 Q00653 2/20 0.38
RELA Q04206 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MAPK1 P28482 2/20 0.38
TP53 P04637 1/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.37
SKP2 Q13309 1/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HSD11B1 P28845 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1148433 0.84 NPC1 (0.38) NPC1RAB9ANFKB1NFKB2RELA
SCHEMBL5329381 0.74 TRPA1 (0.40) TP53GAAALDH1A1
SCHEMBL930752 0.73 KCNMA1 (0.43) NPC1RAB9ANFKB1NFKB2RELA
SCHEMBL3973590 0.69 KCNMA1 (0.38) RAB9ASMN1; SMN2MAPK1POLBGAA
SCHEMBL4088457 0.69 KCNMA1 (0.36) POLBCYP1A2
SCHEMBL4089989 0.69 MGAM (0.35) GAA
SCHEMBL3974423 0.68 KDM4E (0.36) ALDH1A1KMT2A
SCHEMBL4083237 0.68 ALDH1A1 (0.37) NPC1RAB9APOLBGAAHPGD
SCHEMBL3973050 0.67 ALDH1A1 (0.36) SMN1; SMN2POLBGAAHPGDCYP2C9
SCHEMBL4077177 0.67 KDM4E (0.39) RAB9ASMN1; SMN2POLBGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054059-A2 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY Synta Pharmaceuticals Corporation (US) 2009-05-06 EP claimed
WO-2008021364-A2 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY SYNTA PHARMACEUTICALS CORP. (US) 2008-02-21 WO claimed